According to the Low Dose Naltrexone home page [LDN], LDN has been seen to benefit
sarcoidosis, which is considered to be an autoimmune disease.
[Weinstock2017 🕮 ] presents cases in which LDN administration resulted in benefit to the patient.
Dr. Weyrich has been trained to use Low Dose Naltrexone (LDN).
However, Dr. Weyrich has not treated any cases of Sarcoidosis
with LDN.
Please see What is Low Dose Naltrexone?
for more information.
[McCulley2018, pp 62, 339-349] reports that sarcoidosis may be an
autoimmune disorder, and proposes an approach to treating this disease, which should be
supervised by a properly trained medical professional.
Dr. Weyrich has considerable interest in this topic, but has
not treated any cases of sarcoidosis
with Immune System Balancing.
Please see What is Immune System Balancing?
for more information.